3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
53
Ovarian Neoplasms
4
Prostatic Neoplasms
3
Neoplasms
3
Inflammatory Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Solid Tumor
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Cancers
1
Patient Preference
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Multiple Endocrine Neoplasia
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
Her2-Positive Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive Early Breast Cancer
1
HER2 Positive Breast Cancer
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Interventions
Radiotherapy
4
Trastuzumab
3
Paclitaxel
3
Carboplatin
3
Cyclophosphamide
2
talimogene laherparepvec
1
Zoledronic Acid
1
Vorinostat
1
Thiotepa
1
Therapeutics
1
Taxes
1
Surgical Procedures, Operative
1
Radiation
1
Pharmaceutical Preparations
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lapatinib
1
Doxorubicin
1
Docetaxel
1
Cryosurgery
1
Counseling
1
Chemotherapy, Adjuvant
1
Celecoxib
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ductal, Breast
×
pertuzumab
×
Clear all
No trials found.